SUMMARY
Pharyngocutaneous fistula (PCF) is the most common complication following total laryngectomy and the most difficult to manage. It often causes increased morbidity, delays starting adjuvant therapy, prolongs hospitalisation, increases treatment costs and reduces the quality of life (QoL). The objective of this study is to analyse the predisposing factors and the most important nutritional parameters related to the development of PCF in patients undergoing total laryngectomy and to suggest medical alternatives that might improve results. We performed a retrospective study of 69 patients who underwent either primary or salvage total laryngectomy in our department between January 2008 and January 2012. Risk factors for fistula formation were analysed including tumour characteristics (histology, grading, AJCC stage), treatment (primary or salvage surgery, extent of resection, flap reconstruction, preoperative radiotherapy), comorbidity and nutritional status (preoperative haemoglobin, albumin and prealbumin levels and their changes during hospitalisation). Twenty-four patients developed a PCF (overall incidence 34.8%). Fistula formation was significantly higher in patients with diabetes, preoperative malnutrition (identified from low preoperative albumin and prealbumin levels). After specific nutritional evaluation and support, no patient developed a PCF. Risk factors for PCF formation are extensively treated in the literature but identification of high-risk patients is still controversial. Our study demonstrates that nutritional status of the patient, assessed by preoperative albumin, is also an important risk factor for PCF formation in addition to classical factors. Maintenance of a normal perioperative nutritional status can be helpful to avoid this complication.
KEY WORDS: Laryngectomy, Pharyngocutaneous fistula, Malnutrition
RIASSUNTO
La formazione di fistole faringocutanee è una delle complicanze più frequenti dopo laringectomia totale e la più difficile da gestire. La comparsa di una fistola faringocutanea determina spesso aumento della morbidità, ritardo nell'inizio delle terapie adiuvanti, prolungata ospedalizzazione, aumento dei costi di trattamento e riduzione della qualità di vita. L'obiettivo di questo studio è analizzare i principali fattori di rischio e i parametri nutrizionali correlati allo sviluppo di fistole faringocutanee nei pazienti sottoposti a laringectomia totale e valutare i possibili interventi terapeutici finalizzati a ridurre l'incidenza di tale complicanze. Abbiamo effettuato uno studio retrospettivo su 69 pazienti sottoposti presso il nostro istituto a laringectomia totale, come trattamento primitivo o di salvataggio, fra gennaio 2008 e gennaio 2012. I fattori di rischio per la formazione di fistole faringocutanee analizzati sono stati: caratteristiche del tumore (istologia, grading, stadio, ecc.), trattamento (chirurgia primitiva o di salvataggio, estensione della resezione, ricostruzione con lembo, radioterapia preoperatoria, ecc.), comorbidità e stato nutrizionale (valori e trend di emoglobina preoperatoria, albumina e prealbumina). Dopo valutazione e supporto nutrizionale mirato nessun paziente ha sviluppato fistole faringocutanee. L'identificazione dei pazienti ad alto rischio di fistola faringocutanea dopo laringectomia totale è argomento ancora dibattuto in letteratura. Il nostro studio ha dimostrato che lo stato nutrizionale del paziente, valutato attraverso i valori di albumina preoperatoria, è anch'esso un fattore di rischio per lo sviluppo di fistole faringocutanee. Quindi il mantenimento di un stato nutrizionale adeguato può essere utile per evitare tale complicanza.
Introduction
Pharyngocutaneous fistula (PCF) consists of a communication between the digestive tract and the cervical skin that causes the appearance of saliva on the skin surface after swallowing. PCF are classified by Zbar and Funk 1 as either a pharyngocutaneous fistula (an anomalous path connecting the pharynx and the skin) or a pharyngostoma (a direct opening of the pharynx to the skin, often accompanied by skin loss).
PCF is the most common complication after total laryngectomy and the most difficult to manage. The rate for development of a PCF varies from 8% to 22% of patients undergoing total laryngectomy 2-6. It is the major cause of increased morbidity, delays starting of adjuvant therapy, prolongs hospitalisation, increases treatment costs and reduces the quality of life (QoL). In 1998, Parikh et al. estimated a cost of $400,000 per annum to treat fistulae after laryngectomy at their reference care centre in Toronto 7.
The predisposing factors can be divided into patient-related factors (sex, age, smoking, alcohol consumption, diabetes, heart disease 8, gastro-oesophageal reflux disease 9, decreased preoperative haemoglobin 8, albumin 10 and calcium levels, previous surgical treatment, previous radiotherapy 11-13 or chemoradiotherapy, tumour recurrence 14), disease-related factors (stage 13-15, lymph nodes and pharynx involvement 16 17) and treatment-related factors (marginal status 11 12 18, type and technique of closure, experience of the surgeon, preoperative tracheostomy and wound infection).
Risk factors are extensively investigated in the literature, but how to identify high-risk patients is still controversial 11 18. Regarding patient-related factors, it is well known that patients with head and neck cancer are at particular risk for malnutrition for several reasons. Poor dietary habits together with excessive smoking and alcohol consumption are frequently observed among these patients and predispose them to malnutrition 19.
Moreover, the location and stage of the tumour can lead to dysphagia, odynophagia, dysgeusia, or trismus, and result in reduced energy levels and protein intake 20 21. Regardless of the underlying mechanisms, cancer-related weight loss and cancer-related malnutrition are multi-dimensional manifestations that reduce patient well-being 22, tolerance to and prognosis after antineoplastic therapy 23 24, decrease immunological responses to tumour cells 24 25 and resistance to infection 24 26, and increase susceptibility to postoperative complications 24 27, disability and overall cost of care 24. For these reasons, malnutrition can contribute to the development of PCF.
Malnutrition has been reported in 30% to 50% of patients with head and neck malignancies 20 21 28, particularly squamous cell carcinomas of the oropharyngeal and hypopharyngeal regions. The apparent nutritional depletion in these patients reduces their tolerance to treatment 24 28.
In 70 to 80% of cases, the fistulae close spontaneously with local care and tube or parenteral feeding, and further intervention is required in only a minority of cases: the most widely reported technique in use is pectoralis major myofascial flap reinforcement.
In this study, we analyse the predisposing factors and most important nutritional parameters related to the development of PCF in patients undergoing either primary or salvage laryngectomy and suggest medical options to improve the outcomes.
Materials and methods
A retrospective analysis of patients who underwent total laryngectomy at the ENT Department of University Hospital of Modena between January 2008 and January 2012 was carried out. Patients who underwent either primary or salvage total laryngectomy were included.
Surgery
Surgery was performed with curative intent consisting of total laryngectomy as a single procedure or combined with dissection of the neck, thyroidectomy and reconstruction with pectoralis major flap.
Surgical technique and postoperative care were generally standardised.
Pharyngeal reconstruction was performed in three layers: mucosal, fascia and muscular. In all patients, nasogastric feeding was initiated on the first postoperative day and oral feeding was started after a swallowing study on day 7-10.
Risk factors
The primary endpoint was to identify risk factors predisposing patients to fistula formation. A retrospective chart review was conduct. A database was built including data with regard to tumour characteristics (histology, grading, T stage, N stage, AJCC stage), treatment (eventual flap reconstruction, presence of preoperative tracheostomy, primary or salvage surgery, preoperative radiotherapy), comorbidities (history of diabetes or vascular disease), blood values assessing nutritional status (preoperative serum haemoglobin, albumin and prealbumin and their changes during hospitalisation). In fact, preoperative serum albumin was not available for all patients. Since albumin is a blood protein with a lifespan of about 30 days, the value of the first postoperative serum albumin (measured 1 week after surgical intervention) can be considered to be equal to the preoperative value.
Statistical analysis
Pearson's χ2 test was used to evaluate the correlation between the incidence of fistula formation and potential predisposing factors. A p value < 0.05 was considered statistically significant.
Results
Sixty-nine patients were included in the study. Patient and tumour characteristics are detailed in Table I. Median age was 71 years (range 37-88 years). Fistula formation was noted in 24 patients (34.8%). The time of fistula formation is summarised in Table II. Laryngectomy was performed as primary treatment in 51 patients (73.9%). Ten patients underwent pretreatment radiotherapy (14.5%). Preoperative tracheostomy was performed in 15 patients (22.1%). Lateral neck dissection was performed bilaterally in 29 patients (42%) and unilaterally in 22 (31.9%). In the majority of cases, histology was squamous cell carcinoma (94.2%) with different grades of differentiation. Two patients were affected by papillary thyroid carcinoma with larynx extension, and two patients by an undifferentiated carcinoma.
Table I.
N (%) | |
---|---|
Histology | |
SCC | 65 (94.2%) |
Basaloid SCC | 1 (1.4%) |
Papillary thyroid tumour | 2 (2.9%) |
Undifferentiated | 1 (1.4%) |
Gender | |
Male | 59 (85.5%) |
Female | 10 (14.5%) |
Grading | |
G1 | 2.9% |
G2 | 39.1% |
G3 | 49.3% |
GX | 8.7% |
T Stage | |
T1 | 7.2% |
T2 | 8.7% |
T3 | 23.2% |
T4 | 60.9% |
N Stage | |
N0 | 58% |
N1 | 15.9% |
N2a | 0 |
N2b | 13% |
N2c | 7.3% |
N3 | 5.8% |
AJCC Stage | |
I | 4 (5.8%) |
II | 5 (7.2%) |
III | 17 (23.2%) |
IVa | 40 (58%) |
IVb | 1 (1.4%) |
IVc | 2 (2.9%) |
SCC: squamous cell carcinoma.
Table II.
Postoperative day | N (%) |
---|---|
0-11 | 14 (20.3%) |
12-23 | 7 (10.1%) |
24-33 | 2 (2.9%) |
> 33 | 1 (1.4%) |
Table III summarises the results of univariate analysis on the impact of the potential predisposing factors on fistula formation. From the analysis, p values ≤ 0.05 were present for the correlation of fistula formation with diabetes (p = 0.004), and low preoperative albumin and prealbumin levels (p = 0.005).
Table III.
Risk factor | % patients with fistula | % patients without fistula | p value |
---|---|---|---|
G1 | 50 | 50 | 0.18 |
G2 | 22.2 | 78.8 | |
G3 | 48.5 | 51.5 | |
Gx | 16.7 | 83.3 | |
T1 | 66.7 | 33.3 | 0.51 |
T2 | 34.3 | 65.7 | |
T3 | 25 | 75 | |
T4 | 38.1 | 61.9 | |
N+ | 75 | 25 | 0.41 |
N- | 30 | 70 | |
R1 | 31.2 | 68.8 | 0.7 |
R0 | 36.5 | 63.5 | |
AJCC stage I | 50 | 50 | 0.42 |
AJCC stage II | 40 | 60 | |
AJCC stage III | 18.8 | 81.2 | |
AJCC stage IV | 42.5 | 57.5 | |
Previous RT | 40 | 60 | 0.72 |
No previous RT | 34.5 | 65.5 | |
Primary surgery | 41.2 | 58.8 | 0.06 |
Savage surgery | 16.7 | 83.3 | |
Previous tracheostomy | 40 | 60 | 0.56 |
No neck dissection | 22.2 | 77.8 | 0.26 |
Monolateral neck dissection | 31.8 | 68.2 | |
Co-morbidity | |||
Diabetes | 77.8 | 22.2 | 0.004 |
No diabetes | 28.3 | 71.7 | |
Vasculopathy | 42.9 | 57.1 | 0.41 |
No vasculopathy | 31.3 | 68.7 | |
Preop Hb < 12.2 g/dl | 45 | 55 | 0,14 |
Preop Hb > 12.2 g/dl | 30.6 | 69.4 | |
Preop albumin < 3.5 g/dl or prealbumin < 20 mg/dl | 53.6 | 46.6 | 0.005 |
Preop albumin > 3.5 g/dl or prealbumin > 20 mg/dl | ì20 | ì80 | |
Albumin during hospitalisation | 0.4 | ||
Decrease | 80 | 20 | |
Increase | 35.3 | 64.7 | |
Unchanged | 50 | 50 | |
Hb during hospitalisation | 0.34 | ||
Decrease | 34.6 | 65.4 | |
Increase | 44.4 | 55.6 |
Hb: haemoglobin; RT: radiotherapy.
Discussion
From January 2008 to January 2012, our data show an incidence of PCF that is higher than that reported in other studies (34.8% vs 8-22%) 2-6. The retrospective analysis of our results and review of the literature were used to identify the most important risk factors of PCF and to improve perioperative management to avoid this complication. The most comprehensive study on PCF risk factors is a multivariate analysis study by Onal and colleagues 29: a significant relationship was found between development of PCF and previous radiotherapy, positive ipsilateral and contralateral lymph nodes, accompanying systemic disease, pre- and postoperative haemoglobin < 12.2 g/dl and postoperative albumin level < 3.5 g/dl.
In their meta-analysis of postlaryngectomy PCF, Paydarfar and Birkmeyer 30 considered 10 separate variables and established that preoperative radiotherapy, postoperative haemoglobin < 12.5 g/dl, prior tracheotomy and concurrent neck dissection were all significant risk factors for formation of PCF. Similar results were obtain by Galli and De Corso 31: systemic diseases, previous radiotherapy, supraglottic origin of tumour and concurrent radical neck dissection were significantly associated with PCF.
Cavalot et al. 32 demonstrated that diabetes mellitus influenced the development of PCF. However, using the 'Cumulative Illness Rating Scale', Dedivitis et al. 33 found no correlation between systemic disease and development of PCF.
Preoperative radiotherapy, lymph node involvement, positive surgical margins and low pre- and postoperative haemoglobin have been considered relevant risk factors in other studies 11 12 29 34-36. In particular, radiotherapy can increase the incidence of PCF because of the decreased healing capacity secondary to fibrosis and hypovascularisation.
In a recent study, Dirven et al. 37 demonstrated a correlation between risk of PCF and interval between radiotherapy and surgery: patients undergoing salvage surgery within 12 months after radiotherapy had a higher risk of developing PCF compared to those undergoing salvage surgery more than 12 months after radiotherapy (p = 0.014).
In our analysis, a significant correlation was detected between diabetes and the development of PCF, whereas other risk factors such as preoperative radiotherapy and haemoglobin levels were not.
All our patients underwent total laryngectomy with manual closure of the pharynx. Many surgeons prefer to close the pharynx using a stapler. In a prospective study, Dedivitis 38 found no significant difference in the incidence of PCF between the mechanical closure group and the manual suture group. Morton et al. 39 showed that preoperative low serum albumin levels were significantly associated with development of PCF. Our results also showed how poor nutritional status in terms of albumin levels plays a crucial role in PCF development. In fact, low preoperative albumin is an important index of malnutrition.
Only few studies have been carried out on the relationship between nutritional parameters and the incidence of major postoperative complications 19 21 23 24. Unintentional weight loss, and a lesser degree albumin, were predictive for postoperative complications. Weight loss seems to be the most important parameter for predicting major postoperative complications; patients with > 10% weight loss during the 6 months before surgery are at greater risk for the occurrence of major postoperative complications 19 40.
The European Society for Parenteral and Enteral Nutrition (ESPEN) guidelines on enteral nutrition 41 recommend the use of nutritional support for 10-14 days before major surgery in patients with severe nutritional risk (weight loss > 10–15% within 6 months before surgery, BMI < 18.5%, serum albumin < 3 g/dl).
We are presently carrying out a prospective multicentre study to evaluate if the correction of malnutrition can reduce the incidence of PCF in patients with head and neck cancer.
The nutritional status of these patients was defined preoperatively. Thus, in the presence of malnutrition nutritional support is offered before surgery. If there is good preoperative nutritional status, the onset of postoperative malnutrition is thus avoided. Tube feeding for patients starts within 24-48 h after surgery and takes from 2 to 3 days to reach nutritional targets. Energy requirement will be assess by Herris-Benedict equation and each patient will receive 1.2-1.4 g/kg/day of proteins.
We have initiated a standardised enteral nutritional plan tailored on patients requirements in according with current recommendations for enteral feeding.
This prospective study is still on-going. Fifteen patients underwent total laryngectomies in the last year in our hospital. Two patients had preoperative prealbumin < 20 mg/ dl and preoperative albumin < 3.5 g/dl, and can be considered malnourished. No patient developed a PCF.
The present study tried to emphasise that nutritional evaluation should always be performed preoperatively. Malnutrition has to be corrected to avoid a complication such as PCF. Our prospective analysis confirms this, although a small case series bias can be present. Moreover, good nutritional status is known to increase the rates of therapy completion, oncologic survival and post-treatment QoL during all types of therapy for head and neck cancer.
Conclusions
It is important to identify the risk factors associated with formation of PCF to improve perioperative management and avoid this complication. In addition to the classical risk factors for PCF highlighted in many studies 29 30 34, we must also consider the poor nutritional status of the patient as a risk factor, as assessed by preoperative albumin. Preoperative and periodic postoperative evaluations are mandatory in patients with head and neck cancer. Moreover, for the maintenance of normal haematologic values, frequent biochemical analyses and adequate nutritional support are necessary to prevent PCF following total laryngectomy. A multicentre prospective study is ongoing with the aim of evaluating if the correction of malnutrition can reduce the incidence of PCF in patients with head and neck cancer.
References
- 1.Zbar RIS, Funk GF. Current therapy in otolaryngology - head and neck surgery. 6th Edition. Mosby, New York: 1998. Pharyngocutaneous fistula; pp. 314–319. [Google Scholar]
- 2.Fradis M, Podoshin L, Ben David J. Post-laryngectomy pharyngocutaneous fistula – a still unresolved problem. J Laryngol Otol. 1995;109:221–224. doi: 10.1017/s0022215100129743. [DOI] [PubMed] [Google Scholar]
- 3.Herranz J, Sarandeses A, Fernández MF, et al. Complications after total laryngectomy in nonradiated laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg. 2000;122:892–898. doi: 10.1016/S0194-59980070020-9. [DOI] [PubMed] [Google Scholar]
- 4.Hier M, Black MJ, Lafond G. Pharyngo-cutaneous fistulas after total laryngectomy: incidence, etiology and outcome analysis. J Otolaryngol. 1993;22:164–166. [PubMed] [Google Scholar]
- 5.Ikiz AO, Uça M, Güneri EA, et al. Pharyngocutaneous fistula and total laryngectomy: possible predisposing factors, with emphasis on pharyngeal myotomy. J Laryngol Otol. 2000;114:768–771. doi: 10.1258/0022215001904112. [DOI] [PubMed] [Google Scholar]
- 6.Papazoglou G, Doundoulakis G, Terzakis G, et al. Pharyngocutaneous fistula after total laryngectomy: incidence, cause, and treatment. Ann Otol Rhinol Laryngol. 1994;103:801–805. doi: 10.1177/000348949410301010. [DOI] [PubMed] [Google Scholar]
- 7.Parikh SR, Irish JC, Curran AJ, et al. Pharyngocutaneous fistulae in laryngectomy patients: the Toronto Hospital experience. J Otolaryngol. 1998;27:136–140. [PubMed] [Google Scholar]
- 8.Redaelli de Zinis LO, Ferrari L, Tomenzoli D, et al. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Head Neck. 1999;21:131–138. doi: 10.1002/(sici)1097-0347(199903)21:2<131::aid-hed6>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
- 9.Seikaly H, Park P. Gastroesophageal reflux prophylaxis decreases the incidence of pharyngocutaneous fistula after total laryngectomy. Laryngoscope. 1995;105:1220–1222. doi: 10.1288/00005537-199511000-00015. [DOI] [PubMed] [Google Scholar]
- 10.Tsou YA, Hua CH, Lin MH, et al. Comparison of pharyngocutaneous fistula between patients followed by primary laryngopharyngectomy and salvage laryngopharyngectomy for advanced hypopharyngeal cancer. Head Neck. 2001;32:1494–1500. doi: 10.1002/hed.21352. [DOI] [PubMed] [Google Scholar]
- 11.Saki N, Nikakhlagh S, Kazemi M. Pharyngocutaneous fistula after laryngectomy: incidence, predisposing factors, and outcome. Arch Iran Med. 2008;11:314–317. [PubMed] [Google Scholar]
- 12.Lundgren J, Olofsson J. Pharyngocutaneous fistulae following total laryngectomy. Clin Otolaryngol Allied Sci. 1979;4:13–23. doi: 10.1111/j.1365-2273.1979.tb01748.x. [DOI] [PubMed] [Google Scholar]
- 13.Krouse JH, Metson R. Barium swallow is a predictor of salivary fistula following laryngectomy. Otolaryngol Head Neck Surg. 1992;106:254–257. doi: 10.1177/019459989210600310. [DOI] [PubMed] [Google Scholar]
- 14.Andrades P, Pehler SF, Baranano CF, et al. Fistula analysis after radial forearm free flap reconstruction of hypopharyngeal defects. Laryngoscope. 2008;118:1157–1163. doi: 10.1097/MLG.0b013e31816f695a. [DOI] [PubMed] [Google Scholar]
- 15.Soylu L, Kiroglu M, Aydogan B, et al. Pharyngocutaneous fistula following laryngectomy. Head Neck. 1998;20:22–25. doi: 10.1002/(sici)1097-0347(199801)20:1<22::aid-hed4>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
- 16.Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP, et al. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 2001;23:29–33. [PubMed] [Google Scholar]
- 17.Palomar-Asenjo V, Sarroca Capell E, Tobías Gómez S, et al. [[Pharyngocutaneous fistula following total laryngectomy. A case-control study of risk factors implicated in its onset]]. Acta Otorrinolaringol Esp. 2008;59:480–484. [PubMed] [Google Scholar]
- 18.Markou KD, Vlachtsis KC, Nikolaou AC, et al. Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol. 2004;261:61–67. doi: 10.1007/s00405-003-0643-6. [DOI] [PubMed] [Google Scholar]
- 19.Schueren MA, Leeuwen PA, Sauerwein HP, et al. Assessment of malnutrition parameters in head and neck cancer patients and their relation to postoperative complications. Head Neck. 1997;19:419–425. doi: 10.1002/(sici)1097-0347(199708)19:5<419::aid-hed9>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- 20.Jager-Wittenaar H, Dijkstra PU, Vissink A, et al. Critical weight loss in head and neck cancer – prevalence and risk factors at diagnosis: an explorative study. Support Care Cancer. 2007;15:1045–1050. doi: 10.1007/s00520-006-0212-9. [DOI] [PubMed] [Google Scholar]
- 21.Ravasco P, Monteiro-Grillo I, Vidal PM, et al. Nutritional deterioration in cancer: the role of disease and diet. Clin Oncol. 2003;15:443–450. doi: 10.1016/s0936-6555(03)00155-9. [DOI] [PubMed] [Google Scholar]
- 22.Matthews TW, Lampe HB, Dragosz KD, et al. Nutritional status in head and neck cancer patients. J Otolaryngol. 1995;24:87–91. [PubMed] [Google Scholar]
- 23.Wys WD, Begg CTLP, Band PR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69:491–497. doi: 10.1016/s0149-2918(05)80001-3. [DOI] [PubMed] [Google Scholar]
- 24.Kristina N, Pichard C, Lochs H, et al. Prognostic impact of disease- related malnutrition. Clin Nutr. 2008;27:5–15. doi: 10.1016/j.clnu.2007.10.007. [DOI] [PubMed] [Google Scholar]
- 25.Chiara B, Ciorba A, Stomeo F, et al. Immunonutrition in head and neck cancer: have a look before surgery! Eur Arch Otorhinolaryngol. 2012;269:5–8. doi: 10.1007/s00405-011-1725-5. [DOI] [PubMed] [Google Scholar]
- 26.Schueren MAEB, Blomberg A, Flier BME, et al. Differences in immune status between well-nourished and malnourished head and neck cancer patients. Clin Nutr. 1998;17:107–111. doi: 10.1016/s0261-5614(98)80003-4. [DOI] [PubMed] [Google Scholar]
- 27.Schueren MAEB, Leeuwen PAM, Kuik DJ, et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer. 1999;86:519–527. [PubMed] [Google Scholar]
- 28.Brookes GB. Nutritional status – a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1985;93:69–74. doi: 10.1177/019459988509300114. [DOI] [PubMed] [Google Scholar]
- 29.Erdag MA, Arslanoglu S, Onal K, et al. Pharyngocutaneous fistula following total laryngectomy: multivariate analysis of risk factors. Eur Arch Otorhinolaryngol. 2013;270:173–179. doi: 10.1007/s00405-012-2111-7. [DOI] [PubMed] [Google Scholar]
- 30.Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg. 2006;132:67–72. doi: 10.1001/archotol.132.1.67. [DOI] [PubMed] [Google Scholar]
- 31.Galli J, Corso E. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Otolaryngol Head Neck Surg. 2005;133:689–694. doi: 10.1016/j.otohns.2005.07.025. [DOI] [PubMed] [Google Scholar]
- 32.Cavalot AL, Gervasio CF, Nazionale G, et al. Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg. 2000;123:587–592. doi: 10.1067/mhn.2000.110617. [DOI] [PubMed] [Google Scholar]
- 33.Dedivitis RA, Ribeiro KC, Castro MA, et al. Pharyngocutaneous fistula following total laryngectomy. Acta Otorhinolaryngol Ital. 2007;27:2–5. [PMC free article] [PubMed] [Google Scholar]
- 34.Markou KD, Vlachtsis KC, Nikolaou AC, et al. Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol. 2004;261:61–67. doi: 10.1007/s00405-003-0643-6. [DOI] [PubMed] [Google Scholar]
- 35.Hanasono MM, Lin D, Wax MK, et al. Closure of laryngectomy defects in the age of chemoradiation therapy. Head Neck. 2012;34:580–588. doi: 10.1002/hed.21712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Fung K, Teknos TN, Vandenberg CD, et al. Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head Neck. 2007;29:425–430. doi: 10.1002/hed.20492. [DOI] [PubMed] [Google Scholar]
- 37.Dirven R, Swinson BD, Gao K, et al. The assessment of pharyngocutaneous fistula rate in patients treated primarily with definitive radiotherapy followed by salvage surgery of the larynx and hypopharynx. Laryngoscope. 2009;119:1691–1695. doi: 10.1002/lary.20521. [DOI] [PubMed] [Google Scholar]
- 38.Dedivitis RA, Aires FT. Stapler suture of the pharynx after total laryngectomy. Acta Otorhinolaryngol Ital. 2014;34:94–98. [PMC free article] [PubMed] [Google Scholar]
- 39.Morton RP, Fielder CP, Dorman EB. Prediction and prevention of fistulae after major head and neck surgery: a preliminary report. Aust N Z J Surg. 1988;58:951–953. doi: 10.1111/j.1445-2197.1988.tb00099.x. [DOI] [PubMed] [Google Scholar]
- 40. Head and Neck Guideline Steering Committee , author. Evidence based practice guidelines for the nutritional management of patients with head and neck cancer. Sydney: Cancer Council Australia; Available from: http://wiki.cancer.org.au/australia/ COSA:Head and neck cancer nutrition guidelines. [Google Scholar]
- 41.Weimann A, Braga M, Harsanyi L, et al. ESPEN Guidelines on Enteral Nutrition: Surgery including organ transplantation. Clin Nutr. 2006;25:224–244. doi: 10.1016/j.clnu.2006.01.015. [DOI] [PubMed] [Google Scholar]